Latest Commercialization News

Krakatoa Resources has restructured its acquisition of the Zopkhito Antimony-Gold Project in Georgia, adopting a staged earn-in model that reduces upfront payments and prioritises capital deployment into exploration and development activities for 2026.

Fredon, NRW Holdings’ electrical and mechanical arm, has landed contracts worth around $160 million spanning major infrastructure, health, and electric vehicle projects across Australia, with work scheduled through to mid-2028.

Immuron Limited’s unaudited Q3 FY26 sales rose 16% to AUD 1.5 million, driven by Travelan’s expanding footprint in Australia, Canada, and the US despite a stronger Australian dollar.

Memphasys Limited has marked a milestone quarter with revenue surpassing A$100,000, driven by repeat orders and multi-year contracts, signalling its transition to a commercially focused biotech business.

Eden Innovations has unveiled EdenShield®, a new division focused on commercialising advanced carbon nanotube-enhanced materials and dual-fuel systems for defence and critical infrastructure, aiming to tap into a rapidly expanding global aerospace and defence market.

Proteomics International Laboratories has slashed a quarter of its workforce and appointed a new CFO amid a strategic pivot to commercial diagnostics, aiming to save over $1 million annually and sharpen execution.

Buru Energy has secured $5.3 million through a two-tranche placement to fund enhanced development of the Rafael Gas Project, following a significant uplift in project economics from new engineering insights.

Axel REE is accelerating its in situ recovery (ISR) mining trials at the Caladão Project in Brazil, targeting rare earth elements and gallium extraction through a low-cost, environmentally friendly method. The company is fully funded for pilot wellfield trials at the Woolrich deposit, with expansion potential at Paraíso and Tiger Creek.

The ACCC has escalated its scrutiny of Insurance Australia Group’s proposed takeover of RAC Insurance, citing potential substantial lessening of competition in Western Australia’s motor and home insurance markets.

High Peak Royalties has secured an upfront A$50,000 option fee from Massive Metals for a 12-month exclusive call option to acquire its Admiral Bay royalty rights, with potential to extend for another year and a total acquisition price of A$2 million.

Orthocell has swiftly converted regulatory approval into clinical use with the first Remplir™ surgery completed in a US Department of Defense hospital, marking a key step in its US commercial expansion.

Tivan Limited has confirmed its Speewah Fluorite Project can produce premium acidgrade fluorspar suitable for hydrofluoric acid, backed by positive technical assessments from Asian end-users. The company is advancing pilot production and finalising offtake agreements with Sumitomo Corporation and JOGMEC.